Back to User profile » Ms Karen Mezzi

Papers published by Ms Karen Mezzi:


Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study

Larsson K, Lisspers K, Ställberg B, Johansson G, Gutzwiller FS, Mezzi K, Bjerregaard BK, Jorgensen L, Koo H, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1409-1421

Published Date: 21 June 2022

The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study

Larsson K, Janson C, Lisspers K, Ställberg B, Johansson G, Gutzwiller FS, Mezzi K, Bjerregaard BK, Jorgensen L

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:701-713

Published Date: 18 March 2021

Adequacy of Therapy for People with Both COPD and Heart Failure in the UK: Historical Cohort Study

Kostikas K, Rhee CK, Hurst JR, Agostoni P, Cao H, Fogel R, Jones R, Kocks JWH, Mezzi K, Wan Yau Ming S, Ryan R, Price DB

Pragmatic and Observational Research 2020, 11:55-66

Published Date: 2 June 2020

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1325-1337

Published Date: 4 May 2017

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

Vogelmeier C, Zhong NS, Humphries MJ, Mezzi K, Fogel R, Bader G, Patalano F, Banerji D

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3189-3197

Published Date: 14 December 2016